VERA
Vera Therapeutics, Inc.$37.05-0.17 (-0.47%)Prev Close$37.28·MCap$2.69B·P/E—·Vol1.26M·Yield—
▲
Buys (12M)
2
$5.53M
▼
Sells (12M)
13
$4.31M
◆
Net Activity
Net Buyer
$1.21M
●
Active Insiders
9
last 12 mo
Over the past 12 months, insider activity at Vera Therapeutics, Inc. (VERA) has been mixed between buying and selling, with 2 insider purchases totaling $5.53M and 13 insider sales totaling $4.31M. The most recent insider transaction was by Fordyce Marshall (director, officer: PRESIDENT AND CEO), who sold $1.01M worth of shares on Apr 15, 2026. Vera Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $2.69B.
VERA Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 15, 2026 | Fordyce Marshall | director, officer: PRESIDENT AND CEO | Sell | 22,951 | $44.05 | $1.01M | 244,065 |
| Feb 25, 2026 | Grant Sean | officer: CHIEF FINANCIAL OFFICER | Sell | 4,949 | $41.98 | $207.8K | 114,181 |
| Feb 25, 2026 | Brenner Robert | officer: Chief Medical Officer | Sell | 2,151 | $41.98 | $90.3K | 50,947 |
| Feb 25, 2026 | Turner William D. | officer: Chief Regulatory Officer | Sell | 2,187 | $41.98 | $91.8K | 45,313 |
| Feb 25, 2026 | Fordyce Marshall | director, officer: PRESIDENT AND CEO | Sell | 16,925 | $41.98 | $710.6K | 257,163 |
| Feb 25, 2026 | Skelton Laurence Matthew | officer: Chief Commercial Officer | Sell | 1,582 | $41.98 | $66.4K | 64,218 |
| Feb 25, 2026 | Young Joseph R | officer: SVP, FINANCE, CHIEF ACCT OFFCR | Sell | 3,117 | $41.98 | $130.9K | 64,722 |
| Feb 25, 2026 | JOHNSON DAVID LEE | officer: Chief Operating Officer | Sell | 2,579 | $41.98 | $108.3K | 45,727 |
| Dec 15, 2025 | Turner William D. | Chief Regulatory Officer | Sell | 10,000 | $50.08 | $500.8K | 0 |
| Dec 11, 2025 | ENRIGHT PATRICK G | Director | Buy | 5,882 | $42.50 | $250.0K | 0 |
| Dec 8, 2025 | Turner William D. | Chief Regulatory Officer | Sell | 10,000 | $45.31 | $453.1K | 0 |
| Dec 3, 2025 | Turner William D. | Chief Regulatory Officer | Sell | 10,000 | $40.00 | $400.0K | 0 |
| Nov 21, 2025 | Carter Jason S | Chief Legal Officer | Sell | 3,864 | $27.82 | $107.5K | 0 |
| Nov 11, 2025 | Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR | Sell | 15,000 | $29.06 | $435.9K | 0 |
| Jun 23, 2025 | ENRIGHT PATRICK G | Director | Buy | 250,000 | $21.11 | $5.28M | 0 |
| Feb 21, 2025 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 19,688 | $27.78 | $546.9K | 0 |
| Jan 10, 2025 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 17,500 | $41.74 | $730.5K | 143,603 |
| Dec 20, 2024 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 17,500 | $43.07 | $753.7K | 85,942 |
| Dec 13, 2024 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 17,500 | $46.94 | $821.5K | 85,942 |
| Nov 27, 2024 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 19,375 | $47.98 | $929.6K | 85,942 |
| Nov 15, 2024 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 30,625 | $49.50 | $1.52M | 85,942-26% |
| Oct 30, 2024 | SEIDENBERG BETH C | Sell | 15,000 | $48.03 | $720.5K | 131,755 | |
| Oct 25, 2024 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 19,375 | $40.39 | $782.6K | 307,972 |
| Oct 11, 2024 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 15,625 | $38.24 | $597.6K | 307,972 |
| Sep 27, 2024 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 19,450 | $45.97 | $894.1K | 307,972 |
| Sep 20, 2024 | SEIDENBERG BETH C | Sell | 16,476 | $42.26 | $696.2K | 160,376 | |
| Sep 13, 2024 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 15,625 | $37.50 | $585.9K | 307,972 |
| Aug 30, 2024 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 30,320 | $36.84 | $1.12M | 322,667 |
| Aug 23, 2024 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 14,471 | $39.76 | $575.4K | 322,667 |
| Aug 16, 2024 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 15,625 | $37.56 | $586.9K | 337,138 |
| May 17, 2024 | Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR | Sell | 30,837 | $42.30 | $1.30M | 53,171-37% |
| Apr 12, 2024 | Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR | Sell | 5,714 | $40.00 | $228.6K | 53,171 |
| Apr 5, 2024 | Grant Sean | CHIEF FINANCIAL OFFICER | Sell | 118,477 | $39.58 | $4.69M | 96,334-55% |
| Mar 25, 2024 | Katabi Maha | Director | Sell | 834,459 | $40.86 | $34.10M1.2% OS | 3,595,690 |
| Feb 1, 2024 | Katabi Maha | Director | Buy | 161,290 | $31.00 | $5.00M | 3,628,446 |
| Jan 12, 2024 | COMMODORE CAPITAL LP | 10% Owner | Sell | 1,050,000 | $18.00 | $18.90M1.5% OS | 4,400,000 |
| Aug 23, 2023 | Lin Celia | Chief Medical Officer | Sell | 1,490 | $16.65 | $24.8K | 11,010 |
| Aug 23, 2023 | Fordyce Marshall | President and CEO | Sell | 5,210 | $16.66 | $86.8K | 243,361 |
| Aug 23, 2023 | Curley Joanne | Chief Development Officer | Sell | 1,490 | $16.66 | $24.8K | 26,962 |
| Jun 23, 2023 | Grant Sean | Chief Financial Officer | Buy | 5,000 | $16.60 | $83.0K | 5,992+504% |
| Jun 22, 2023 | COMMODORE CAPITAL LP | 10% Owner | Buy | 448,217 | $15.17 | $6.80M0.6% OS | 5,450,000 |
| Apr 3, 2023 | SEIDENBERG BETH C | Director | Buy | 2,300 | $7.24 | $16.7K | 1,949,295 |
| Mar 30, 2023 | SEIDENBERG BETH C | Director | Buy | 23,908 | $7.24 | $173.2K | 1,946,995 |
| Mar 28, 2023 | SEIDENBERG BETH C | Director | Buy | 3,466 | $7.24 | $25.1K | 1,923,087 |
| Mar 21, 2023 | SEIDENBERG BETH C | Director | Buy | 89,297 | $7.13 | $636.9K | 1,919,621 |
| Mar 17, 2023 | SEIDENBERG BETH C | Director | Buy | 92,941 | $7.10 | $660.3K | 1,830,324 |
| Mar 14, 2023 | SEIDENBERG BETH C | Director | Buy | 48,003 | $7.16 | $343.5K | 1,737,383 |
| Mar 7, 2023 | SEIDENBERG BETH C | Director | Buy | 1,000 | $7.25 | $7.2K | 1,689,380 |
| Mar 3, 2023 | SEIDENBERG BETH C | Director | Buy | 23,478 | $7.24 | $170.0K | 1,688,380 |
| Feb 27, 2023 | SEIDENBERG BETH C | Director | Buy | 200 | $7.24 | $1.4K | 1,664,902 |
Showing 1–50 of 86
1 / 2
VERA Insider Buying Activity
The following table shows recent insider purchases of Vera Therapeutics, Inc. (VERA) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Dec 11, 2025 | ENRIGHT PATRICK G | Director | Buy | 5,882 | $42.50 | $250.0K | 0 |
| Jun 23, 2025 | ENRIGHT PATRICK G | Director | Buy | 250,000 | $21.11 | $5.28M | 0 |
| Feb 1, 2024 | Katabi Maha | Director | Buy | 161,290 | $31.00 | $5.00M | 3,628,446 |
| Jun 23, 2023 | Grant Sean | Chief Financial Officer | Buy | 5,000 | $16.60 | $83.0K | 5,992+504% |
| Jun 22, 2023 | COMMODORE CAPITAL LP | 10% Owner | Buy | 448,217 | $15.17 | $6.80M0.6% OS | 5,450,000 |
| Apr 3, 2023 | SEIDENBERG BETH C | Director | Buy | 2,300 | $7.24 | $16.7K | 1,949,295 |
| Mar 30, 2023 | SEIDENBERG BETH C | Director | Buy | 23,908 | $7.24 | $173.2K | 1,946,995 |
| Mar 28, 2023 | SEIDENBERG BETH C | Director | Buy | 3,466 | $7.24 | $25.1K | 1,923,087 |
| Mar 21, 2023 | SEIDENBERG BETH C | Director | Buy | 89,297 | $7.13 | $636.9K | 1,919,621 |
| Mar 17, 2023 | SEIDENBERG BETH C | Director | Buy | 92,941 | $7.10 | $660.3K | 1,830,324 |
| Mar 14, 2023 | SEIDENBERG BETH C | Director | Buy | 48,003 | $7.16 | $343.5K | 1,737,383 |
| Mar 7, 2023 | SEIDENBERG BETH C | Director | Buy | 1,000 | $7.25 | $7.2K | 1,689,380 |
| Mar 3, 2023 | SEIDENBERG BETH C | Director | Buy | 23,478 | $7.24 | $170.0K | 1,688,380 |
| Feb 27, 2023 | SEIDENBERG BETH C | Director | Buy | 200 | $7.24 | $1.4K | 1,664,902 |
VERA Insider Selling Activity
The following table shows recent insider sales of Vera Therapeutics, Inc. (VERA) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 15, 2026 | Fordyce Marshall | director, officer: PRESIDENT AND CEO | Sell | 22,951 | $44.05 | $1.01M | 244,065 |
| Feb 25, 2026 | Grant Sean | officer: CHIEF FINANCIAL OFFICER | Sell | 4,949 | $41.98 | $207.8K | 114,181 |
| Feb 25, 2026 | Brenner Robert | officer: Chief Medical Officer | Sell | 2,151 | $41.98 | $90.3K | 50,947 |
| Feb 25, 2026 | Turner William D. | officer: Chief Regulatory Officer | Sell | 2,187 | $41.98 | $91.8K | 45,313 |
| Feb 25, 2026 | Fordyce Marshall | director, officer: PRESIDENT AND CEO | Sell | 16,925 | $41.98 | $710.6K | 257,163 |
| Feb 25, 2026 | Skelton Laurence Matthew | officer: Chief Commercial Officer | Sell | 1,582 | $41.98 | $66.4K | 64,218 |
| Feb 25, 2026 | Young Joseph R | officer: SVP, FINANCE, CHIEF ACCT OFFCR | Sell | 3,117 | $41.98 | $130.9K | 64,722 |
| Feb 25, 2026 | JOHNSON DAVID LEE | officer: Chief Operating Officer | Sell | 2,579 | $41.98 | $108.3K | 45,727 |
| Dec 15, 2025 | Turner William D. | Chief Regulatory Officer | Sell | 10,000 | $50.08 | $500.8K | 0 |
| Dec 8, 2025 | Turner William D. | Chief Regulatory Officer | Sell | 10,000 | $45.31 | $453.1K | 0 |
| Dec 3, 2025 | Turner William D. | Chief Regulatory Officer | Sell | 10,000 | $40.00 | $400.0K | 0 |
| Nov 21, 2025 | Carter Jason S | Chief Legal Officer | Sell | 3,864 | $27.82 | $107.5K | 0 |
| Nov 11, 2025 | Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR | Sell | 15,000 | $29.06 | $435.9K | 0 |
| Feb 21, 2025 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 19,688 | $27.78 | $546.9K | 0 |
| Jan 10, 2025 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 17,500 | $41.74 | $730.5K | 143,603 |
| Dec 20, 2024 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 17,500 | $43.07 | $753.7K | 85,942 |
| Dec 13, 2024 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 17,500 | $46.94 | $821.5K | 85,942 |
| Nov 27, 2024 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 19,375 | $47.98 | $929.6K | 85,942 |
| Nov 15, 2024 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 30,625 | $49.50 | $1.52M | 85,942-26% |
| Oct 30, 2024 | SEIDENBERG BETH C | Sell | 15,000 | $48.03 | $720.5K | 131,755 | |
| Oct 25, 2024 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 19,375 | $40.39 | $782.6K | 307,972 |
| Oct 11, 2024 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 15,625 | $38.24 | $597.6K | 307,972 |
| Sep 27, 2024 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 19,450 | $45.97 | $894.1K | 307,972 |
| Sep 20, 2024 | SEIDENBERG BETH C | Sell | 16,476 | $42.26 | $696.2K | 160,376 | |
| Sep 13, 2024 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 15,625 | $37.50 | $585.9K | 307,972 |
| Aug 30, 2024 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 30,320 | $36.84 | $1.12M | 322,667 |
| Aug 23, 2024 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 14,471 | $39.76 | $575.4K | 322,667 |
| Aug 16, 2024 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 15,625 | $37.56 | $586.9K | 337,138 |
| May 17, 2024 | Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR | Sell | 30,837 | $42.30 | $1.30M | 53,171-37% |
| Apr 12, 2024 | Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR | Sell | 5,714 | $40.00 | $228.6K | 53,171 |
| Apr 5, 2024 | Grant Sean | CHIEF FINANCIAL OFFICER | Sell | 118,477 | $39.58 | $4.69M | 96,334-55% |
| Mar 25, 2024 | Katabi Maha | Director | Sell | 834,459 | $40.86 | $34.10M1.2% OS | 3,595,690 |
| Jan 12, 2024 | COMMODORE CAPITAL LP | 10% Owner | Sell | 1,050,000 | $18.00 | $18.90M1.5% OS | 4,400,000 |
| Aug 23, 2023 | Lin Celia | Chief Medical Officer | Sell | 1,490 | $16.65 | $24.8K | 11,010 |
| Aug 23, 2023 | Fordyce Marshall | President and CEO | Sell | 5,210 | $16.66 | $86.8K | 243,361 |
| Aug 23, 2023 | Curley Joanne | Chief Development Officer | Sell | 1,490 | $16.66 | $24.8K | 26,962 |
VERA Insiders
Similar Stocks to VERA
VRTX
Vertex Pharmaceuticals Incorporated
$429.47+0.81%
$111.71B
REGN
Regeneron Pharmaceuticals, Inc.
$734.06-1.39%
$77.87B
ALNY
Alnylam Pharmaceuticals, Inc.
$303.44-1.64%
$41.24B
INSM
Insmed Incorporated
$135.11-0.64%
$30.79B
RVMD
Revolution Medicines, Inc.
$144.62+9.92%
$29.51B
UTHR
United Therapeutics Corporation
$566.69+0.03%
$25.13B
MRNA
Moderna, Inc.
$47.16-3.17%
$21.42B
RPRX
Royalty Pharma plc
$49.40-0.50%
$21.20B